Abstract: The present invention relates to orally ingestible, pharmaceutical compositions containing at least one pharmaceutical active and a taste masking component.
Abstract: A clear, hypoallergenic sinus and allergy medication is orally administered in an aqueous, liquid dosage form. The formulation provides effective sinus and allergy relief without alcohol or dyes which adversely affect many allergy sufferers. Said relief is provided while still maintaining aesthetic appeal or pleasant taste and texture.
Abstract: Methods for reducing the risk of or preventing infections by bacterial pathogens in vivo. In particular, a method for reducing the risk of P. aeruginosa infection in vivo in compromised hosts such as cystic fibrosis patients. The methods involve the use of dextran or dextran sulphate as the active ingredient.
Abstract: A powder-form composition of 2-acetyl-1-pyrroline incorporated with a support of maltodextrin and/or cyclodextrin. The composition is prepared by hydrolyzing a 2-(1-alkoxyethenyl)-1-pyrroline with an acid to obtain a reaction medium, adding an equimolar amount of a base to the reaction medium to obtain a neutralized reaction medium containing 2-acetyl-1-pyrroline, combining maltodextrin and/or cyclodextrin with the neutralized reaction medium to obtain a support solution and freeze-drying the support solution to obtain the composition.
Abstract: The new therapeutic composition remedying the disorders appearing in the otolaryngological sphere comprises a very large quantity of vitamin A per dose, each dose containing 40,000 to 60,000 IU of vitamin A for a treatment of three to four days.
Abstract: A method of treating a pathological condition of an internal organ in a patient which comprises topically applying capsaicin to the skin of the patient containing nerves which lead to the spinal cord segments corresponding to the internal organ without the need of systemic absorption of the capsaicin.
Abstract: Present invention is a non-toxic, flavor stable, pleasant tasting composition releasing Zn.sup.2+ from compositions containing a highly ionizable zinc compound other than zinc gluconate that reduces the duration of common colds in humans. The composition is used in the oral cavity of a human suffering from a common cold. The composition comprises highly ionizable zinc compounds and a pharmaceutically acceptable carrier such as fructose, dextrose or sucrose with various additions. Compositions are unique in that they are non-toxic, pleasant tasting and do not have an offensive aftertaste, yet deliver zinc ions into oral tissues which may be used to treat common colds, reduce the duration of common colds or cure common colds in humans in need of such treatment. Compositions are non-toxic, thermally, chemically and flavor stable. The compositions may be prepared in the form of compressed tablets, lozenges, powders, liquids or chewing gums.
Abstract: The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and microcrystalline cellulose; an effective amount of taste masking compositions; and water, as well as a process for producing such aqueous pharmaceutical suspensions.
Abstract: 2-benzoylamino-3,5-dibromo-N-(4-hydroxycyclohexyl)benzylamine of formula (I), and pharmaceutically acceptable acid addition salts have antitussive and mucus regulating activities.
Abstract: A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the non-sedating antihistamine, loratadine, and use of the said composition for treating patients showing the signs and symptoms associated with upper respiratory diseases and nasal congestion are disclosed.
Abstract: An ingestible mixture containing the extract from the chuchuhuasha plant is useful for the alleviation of cramps, colds, and nasal congestion. The mixture comprises: the therapeutic component being the extract from the chuchuhuasha plant; a taste and fermentation component being honey; and a liquid extraction component being chosen from the group consisting of alcohol and water. According to the present invention, the mixture comprises about 20% to 50% by weight of the extract from the chuchuhuasha plant as the therapeutic component; about 20% to 50% by weight of water or alcohol as the liquid extraction component; and about 25% to 35% by weight of honey as the taste and fermentation component. According to a specific embodiment of the present invention, the mixture comprises about 35% by weight of the extract from the chuchuhuasha plant; about 35% by weigh of water or alcohol; and about 30% by weight of honey.
Abstract: The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and microcrystalline cellulose; an effective amount of taste masking compositions; and water, as well as a process for producing such aqueous pharmaceutical suspensions.
Abstract: The present invention encompasses the novel method of using .+-.phenylpropanolamine to induce mucous secretion in the upper airways of persons afflicted with sinusitis or otitis media characterized by retention of thickened respiratory secretions. These methods comprise administering to such person a safe and effective amount of .+-.phenylpropanolamine. It also encompasses certain novel oral compositions consisting essentially of l(-)-norephedrine and a pharmaceutically-acceptable excipient base.
Abstract: The present invention relates to a syrup composition characterized in that the composition contains phenobarbital or acetaminophen, a polyhydric alcohol and/or a polymer of a polyhydric alcohol, and a water soluble macromolecule, and the weight ratio of phenobarbital to the polyhydric alcohol and/or the polymer of the polyhydric alcohol is from 1:20 to 1:100, and the weight ratio of phenobarbital to the water soluble macromolecule is from 1:1 to 1:20, which has a reduced bitterness and is easy to take.
Abstract: Methods and formulations are provided for alleviating the dryness of mucosal membranes in the upper and lower respiratory tract and gastrointestinal tract. The compositions are formulated into aerosol sprays and delayed release tablets which include eriodictyon fluid which is a Yerba Santa extract. The formulations may additionally contain other components such as preservatives, bronchodilators, choleretics, antibiotics, topical anesthetics, coloring agents, emulsifiers, and the like. The Yerba Santa-based compositions of the invention are administered to an affected patient to alleviate or prevent dryness on the mucosal membranes of the respiratory and gastrointestinal tracts.
Abstract: The subject invention involves compositions and methods of using loperamide and related compounds for treatment of symptoms associated with respiratory diseases.
Type:
Grant
Filed:
January 25, 1991
Date of Patent:
May 26, 1992
Assignee:
The Procter & Gamble Company
Inventors:
Sheri A. Gilbert, Haruko Mizoguchi, Robert P. Charest, Timothy P. O'Neill, Ronald L. Smith
Abstract: A method of treatment of cough and/or bronchoconstriction in mammals, including humans, which method comprises the administration to the mammal in need of such treatment, an effective amount of a 5-HT.sub.3 receptor antagonist.
Abstract: Thermally, chemically and flavor stable compositions for oral absorption by a human containing zinc acetate with a consumable, sweet pharmaceutical carrier and prepared in the form of a pleasant testing lozenge, powder, liquid or chewable composition for delivery of zinc to the oral and oral pharyngeal mucosa of a human with said composition being absent the normal offensive aftertaste of zinc, and being primarily intended for use in treating common colds or in nutritional supplementation.
Abstract: An opiate antagonist or a pharmaceutically acceptable salt thereof is used to treat emotional numbness associated with Post Traumatic Stress Disorder and other psychopathologic conditions.
Abstract: An oral composition containing ionizable compounds of zinc flavor-masked with anethole and prepared in the forms of pleasant tasting lozenges, soft candies, syrups, powders and chewing gums for delivery of zinc to the oral and oral pharyngeal mucosa of a human with said composition being absent the taste or aftertaste of zinc, and being primarily intended for use in treating the common cold.
Abstract: Disclosed is a hard confection containing Palatinit (hydrogenated isomaltulose) and a medicinally active ingredient. Such a formulation has been found to dissolve more slowly than similar formulations based on sugar rendering them suitable for dispensing the active ingredient over an extended period of time.
Abstract: Administration of a resistance imparting agent characterized by comprising an organogermanium compound as an effective component shown by the following formula (I); ##STR1## (wherein A and B denote hydrogen or lower alkyl groups such as methyl and ethyl groups, R denotes a combination of one or two atoms or groups shown by A or B, and X denotes an oxygen or nitrogen atom) in patients having low pulmonary function (35 examples of a group to which the agent was administered, 34 examples of an untreated group) showed that the number complaining of cold syndrome was 13 in the first group and 30 in the second group, which the total number of days during which remedies were used by the first group for cold syndrome was 79 days (of a total possible of 4635 days) compared with 295 days (of a total possible of 4860 days) for the untreated group, and that patients having low pulmonary function were apparently endowed with resistance to cold syndrome. Furthermore, no remarkable side-effects were observed.
Abstract: Novel antitussive and anesthesic liquid compositions of matter for oral use comprising an effective oral antitussive drug and phenol, and method of using same.
Abstract: A cough drop is provided comprising a hard candy outer shell and a powdered centerfill containing a rapidly-dissolving powder such as dextrose monohydrate and an active ingredient such as menthol and eucalyptus which is preferably in the form of a liquid blend and a spray-dried powder. The hard candy outer shell also contains menthol and eucalyptus as a liquid blend.When the outer shell is dissolved in the mouth or the centerfill is bitten into, the rapidly-dissolving powder acts to enhance the active-ingredient's activity in the mouth so that a discernible vaporization of active-ingredient is felt.
Abstract: An N-acetyl-p-aminophenol composition capable of being directly formed into a tablet having high hardness, short disintegration time and short dissolution time is disclosed. The composition includes N-acetyl-p-aminophenol, a pharmaceutically acceptable pregelatinized starch, a pharmaceutically acceptable lubricant, water and optionally an auxiliary binder such as polyvinylpyrrolidone. Also disclosed is a method for preparing the composition which includes drying a fluidized bed of the composition in a fluid bed granulator-dryer.
Abstract: An N-acetyl-p-aminophenol composition capable of being directly formed into a tablet having high hardness, short disintegration time and short dissolution time is disclosed. The composition includes N-acetyl-p-aminophenol, a pharmaceutically acceptable pregelatinized starch, a pharmaceutically acceptable lubricant, water and optionally an auxiliary binder such as polyvinylpyrrolidone. Also disclosed is a method for preparing the composition which includes drying a fluidized bed of the composition in a fluid bed granulator-dryer.
Abstract: The symptoms of chronic alveolar emphysema in horses are palliated by daily feeding the effected horses a handful of the red berries from the staghorn sumac for a period of at least about two weeks.
Abstract: A medicament adsorbate containing a magnesium trisilicate having a surface area of at least 400 m.sup.2 /g and having a flake-like structure with multiple interstitial spaces, and having adsorbed therein from about 1% to about 20% by weight of the adsorbate of a medicament drug, wherein the medicament drug is an antihistamine.
Type:
Grant
Filed:
December 19, 1985
Date of Patent:
February 10, 1987
Assignee:
Warner-Lambert Company
Inventors:
David Peters, John Denick, Jr., Anil K. Talwar
Abstract: Disclosed are an acetaminophen composition containing a minor amount of a pheniramine maleate, a spray-drying method for preparing the composition and orally administerable analgesic antihistaminic tablets formed from the composition.